Cycurion, Inc. (CYCU) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cycurion, Inc., a Delaware corporation, on April 15, 2025, covering events occurring on April 9 and April 11, 2025. The Company is an emerging growth company with its principal executive offices in McLean, Virginia. Its common stock (CYCU) and redeemable warrants (CYCUW) are listed on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status regarding stock listing requirements.
Material Changes and Listing Deficiencies
The Company received three separate notices from Nasdaq indicating failures to meet continued listing standards:
- Minimum Bid Price Deficiency (April 9 Notice): The closing bid price of the Company's common stock was below $1.00 per share for 30 consecutive business days. The Company has 180 calendar days (until October 6, 2025) to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- Market Value of Listed Securities (MVLS) Deficiency (April 11 Notice): The Company failed to maintain the required minimum MVLS of $50,000,000 for 30 consecutive business days. The Company has 180 calendar days (until October 8, 2025) to rectify this by achieving an MVLS of at least $50,000,000 for 10 consecutive business days.
- Market Value of Publicly Held Shares (MVPHS) Deficiency (April 11 Notice): The Company failed to maintain the required minimum MVPHS of $15,000,000 for 30 consecutive business days. The Company has 180 calendar days (until October 8, 2025) to rectify this by achieving an MVPHS of at least $15,000,000 for 10 consecutive business days.
Failure to regain compliance within the specified periods may result in delisting, though the Company retains the right to appeal such determinations to a Nasdaq hearings panel. The Company may consider a reverse stock split to cure deficiencies if necessary.
Outlook, Risks, and Management Commentary
Management states that the Company is currently evaluating potential actions to regain compliance with all applicable listing requirements. The filing explicitly states there can be no assurance that the Company will be successful in maintaining its listing on The NASDAQ Global Market. The notices do not have an immediate effect on the trading of the Company's common stock, provided other listing requirements are met.
Investor Verification Checklist
- Verify the current closing bid price of CYCU stock to assess progress toward the $1.00 minimum requirement.
- Monitor the Company's Market Value of Listed Securities (MVLS) and Market Value of Publicly Held Shares (MVPHS) against the $50 million and $15 million thresholds, respectively.
- Watch for announcements regarding a potential reverse stock split or other capital structure changes intended to cure the deficiencies.
- Track the compliance deadlines of October 6, 2025 (bid price) and October 8, 2025 (market value standards).
- Review future filings for any updates on the status of appeals or further communications from Nasdaq.